These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 15306933)

  • 21. Local immune response in serous papillary carcinoma of the endometrium.
    Tamiolakis D; Venizelos J; Lambropoulou M; Nikolaidou S; Tsikouras P; Jivannakis T; Papadopoulos N
    Histol Histopathol; 2005 Apr; 20(2):403-8. PubMed ID: 15736043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
    Carcangiu ML; Chambers JT
    Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.
    Zheng W; Yi X; Fadare O; Liang SX; Martel M; Schwartz PE; Jiang Z
    Am J Surg Pathol; 2008 Feb; 32(2):304-15. PubMed ID: 18223334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
    Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
    Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cytology in serous and endometrioid endometrial cancer.
    Roelofsen T; Geels YP; Pijnenborg JM; van Ham MA; Zomer SF; van Tilburg JM; Snijders MP; Siebers AG; Bulten J; Massuger LF
    Int J Gynecol Pathol; 2013 Jul; 32(4):390-8. PubMed ID: 23722512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
    Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
    Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
    Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF
    Gynecol Oncol; 1998 Oct; 71(1):59-63. PubMed ID: 9784320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MDM2 and p53 protein expression in the histologic subtypes of endometrial carcinoma.
    Ambros RA; Sheehan CE; Kallakury BV; Ross JS; Malfetano J; Paunovich E; Figge J
    Mod Pathol; 1996 Dec; 9(12):1165-9. PubMed ID: 8972476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal uterine serous carcinoma: a clinicopathological study of 40 cases.
    Hui P; Kelly M; O'Malley DM; Tavassoli F; Schwartz PE
    Mod Pathol; 2005 Jan; 18(1):75-82. PubMed ID: 15389257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
    Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
    Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decreased expression of 14-3-3σ is predictive of poor prognosis for patients with human uterine papillary serous carcinoma.
    Suzuki F; Nagase S; Suzuki K; Oba E; Hiroki E; Matsuda Y; Akahira J; Nishigori H; Sugiyama T; Otsuki T; Yoshinaga K; Takano T; Niikura H; Ito K; Sasano H; Yaegashi N
    Tohoku J Exp Med; 2013 Nov; 231(3):193-9. PubMed ID: 24201220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Uterine serous carcinoma and endometrial intraepithelial carcinoma arising in endometrial polyps: report of 5 cases, including 2 associated with tamoxifen therapy.
    McCluggage WG; Sumathi VP; McManus DT
    Hum Pathol; 2003 Sep; 34(9):939-43. PubMed ID: 14562291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.
    Nordström B; Strang P; Lindgren A; Bergström R; Tribukait B
    Anticancer Res; 1996; 16(2):899-904. PubMed ID: 8687148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.
    Fadare O; Zheng W
    Diagn Pathol; 2008 Feb; 3():6. PubMed ID: 18261213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.
    Sherman ME; Bur ME; Kurman RJ
    Hum Pathol; 1995 Nov; 26(11):1268-74. PubMed ID: 7590703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serous papillary adenocarcinoma of the endometrium].
    Lampe B; Kürzl R; Kindermann G
    Geburtshilfe Frauenheilkd; 1991 Jan; 51(1):45-50. PubMed ID: 2026299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.
    Massuger L; Roelofsen T; Ham Mv; Bulten J
    Med Hypotheses; 2010 May; 74(5):859-61. PubMed ID: 20022435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serous papillary carcinoma of the endometrium arising from endometrial polyps: a clinical, histological, and immunohistochemical study of 13 cases.
    Trahan S; Têtu B; Raymond PE
    Hum Pathol; 2005 Dec; 36(12):1316-21. PubMed ID: 16311126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine papillary serous carcinoma evolves via a p53-driven pathway.
    Moll UM; Chalas E; Auguste M; Meaney D; Chumas J
    Hum Pathol; 1996 Dec; 27(12):1295-300. PubMed ID: 8958301
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological and immunohistochemical characterization of papillary proliferation of the endometrium: A single institutional experience.
    Park CK; Yoon G; Cho YA; Kim HS
    Oncotarget; 2016 Jun; 7(26):39197-39206. PubMed ID: 27322430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.